Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Categories
  3. Oncology

Oncology Research

Browse the latest research summaries in the field of oncology for spinal cord injury patients and caregivers.

Showing 141-150 of 200 results

UrologyOncology

From Interferon to Checkpoint Inhibition Therapy—A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette–Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC)

Cancers, 2022 • January 29, 2022

The urinary bladder is an immunogenic organ. The occurrence of BC permanently alters the immune landscape of the bladder. Immunizing therapies, either as bladder instillation or as intravenously or or...

KEY FINDING: Durvalumab plus Oportuzumab monatox, Pembrolizumab, and Nadofaragene firadenovec (NF) show complete response (CR) rates of 41.6%, 40.6%, and 59.6% after 3 months.

Read Summary
OncologyGenetics

Antagonistic L1 Adhesion Molecule Mimetic Compounds Inhibit Glioblastoma Cell Migration In Vitro

Biomolecules, 2022 • March 12, 2022

This study identifies three L1 antagonistic mimetics—anagrelide, 2-hydroxy-5-fluoropyrimidine, and mestranol—that inhibit the migration of cultured tumor cells in an L1-dependent manner. The mimetics ...

KEY FINDING: Anagrelide, 2-hydroxy-5-fluoropyrimidine, and mestranol competitively inhibit antibody 324 binding to L1, suggesting they interfere with L1's function.

Read Summary
OncologyPharmacologyBiomedical

Lipid-Based Nano-Sized Cargos as a Promising Strategy in Bone Complications: A Review

Nanomaterials, 2022 • March 30, 2022

This review highlights the potential of lipid-based nanomaterials in addressing bone complications, particularly bone metastasis, by offering targeted drug delivery and improved therapeutic efficacy. ...

KEY FINDING: Lipid-based nanocarriers can be modified with bisphosphonates to enhance their affinity for bone, allowing for improved drug delivery to targeted areas within the bone structure.

Read Summary
OncologyRegenerative MedicineBiomedical

Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy

Pharmaceutics, 2022 • March 29, 2022

With the deep understanding of the effector mechanisms of immune cells, the biomimetic and materials-potentiated cell engineering is refreshing its meaning. The combination of cell or cell-derived com...

KEY FINDING: Materials-potentiated cell engineering strategies are to endow immune cells with different supportive components (also known as backpack strategies), or functional materials to enhance their anti-tumor effects, prevent and rescue their dysfunction, maintain and restore their anti-tumor phenotype

Read Summary
OncologyImmunologyBioinformatics

A Prognosis Marker Dynein Cytoplasmic 1 Heavy Chain 1 Correlates with EMT and Immune Signature in Liver Hepatocellular Carcinoma by Bioinformatics and Experimental Analysis

Disease Markers, 2022 • May 11, 2022

The study investigates the role of DYNC1H1 in LIHC using bioinformatics and experimental analysis, finding that DYNC1H1 expression is associated with clinicopathological features and poor prognosis. G...

KEY FINDING: DYNC1H1 expression levels were associated with T classification, pathologic stage, histologic grade, and serum AFP levels in LIHC patients.

Read Summary
OncologySurgery

Spinal metastasis of parotid acinic cell carcinoma followed by intradural extramedullary recurrence: illustrative case

J Neurosurg Case Lessons, 2021 • December 20, 2021

This case report describes an extremely rare instance of intradural extramedullary (IDEM) metastasis of parotid acinic cell carcinoma (ACC) in a 79-year-old male with a 29-year history of the disease....

KEY FINDING: The patient presented with progressive cervical myelopathy 29 years after initial diagnosis of parotid ACC, indicating a rare late recurrence and metastasis.

Read Summary
UrologyOncologyMedical Imaging

The Diagnostic Value of the Added MR Imaging of the Scrotum in the Preoperative Workup of Sonographically Indeterminate Testicular Lesions—A Retrospective Multicenter Analysis

Cancers, 2022 • July 23, 2022

The purpose of this study was to retrospectively analyze the diagnostic accuracy of magnetic resonance imaging (MRI) examinations of the scrotum in comparison with standard ultrasound (US) and histopa...

KEY FINDING: MRI shows good sensitivity and specificity for the estimation of testicular tumors in this collective.

Read Summary
OncologyBioinformatics

The role of tetraspanins pan-cancer

iScience, 2022 • August 19, 2022

Tetraspanins (TSPANs) are a class of four-transmembrane segmented proteins. The precise functions of TSPANs and their roles in pan-cancer are unclear. In this work, we analyzed 24 TSPAN family genes i...

KEY FINDING: TSPAN3-6, TSPAN9-11, TSPAN13-15, TSPAN17, TSPAN31, TSPAN33 are mainly upregulated, and TSPAN2, TSPAN7 are mainly downregulated.

Read Summary
OncologyGeneticsBioinformatics

Alternative ANKHD1 transcript promotes proliferation and inhibits migration in uterine corpus endometrial carcinoma

npj Genomic Medicine, 2022 • August 8, 2022

Based on TCGA and TCGASpliceSeq databases, gene expression and the AS data of UCEC samples were retrieved. These findings indicate that HSPB1, a splicing factor, regulates the expression of ANKHD1-BP3 ...

KEY FINDING: An alternate terminator of ANKHD1 transcripts named ANKHD1-BP3 was found to be significantly related to metastasis and OS in UCEC and significantly associated with HSPB1.

Read Summary
OncologyImmunologyBioinformatics

Integrated Bioinformatics and Experimental Analysis Identified TRIM28 a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Liver Hepatocellular Carcinoma

Computational and Mathematical Methods in Medicine, 2022 • October 1, 2022

This study explores the role of TRIM28 in LIHC, finding that its expression is upregulated in tumors and associated with poor prognosis. The research identifies correlations between TRIM28 expression ...

KEY FINDING: High TRIM28 expression level was associated with T classification, pathologic stage, histologic grade, and serum AFP levels.

Read Summary
Previous
1...141516...20
Next